Michael Hehenberger is founder and partner of HM NanoMed LLC, Connecticut, USA. He retired in 2013 after a long career with IBM. He obtained his PhD and DSc in quantum chemistry from Uppsala University, Sweden. Throughout his IBM career, he has led collaborations with academic and global industrial life sciences organizations. His efforts have been documented in about 50 publications and book chapters. His first book, titled Nanomedicine: Science, Business, and Impact, was published by Jenny Stanford Publishing in 2015. Zhan Xia is deputy secretary of the China Science Writers Association, project manager of the National High Technology Research and Development Program ("863" Program) of China, and core member of the Guangdong Provincial Innovation Team. He is also a popular science expert of the Chinese Genetics Society. He has published dozens of academic papers in internationally renowned magazines, more than 100 column articles in journals, and 14 books. He is a recipient of the National Publishing Fund Project, and National Outstanding Science Works Award.